Home › Funds › CASTLEARK MANAGEMENT LLC › LGND
CASTLEARK MANAGEMENT LLC position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
CASTLEARK MANAGEMENT LLC reported holding 62,043 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$19.6M, representing 0.53% of its reported portfolio and ranking #34 among its reported holdings. CASTLEARK MANAGEMENT LLC has disclosed LGND holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How CASTLEARK MANAGEMENT LLC's LGND position evolved
CASTLEARK MANAGEMENT LLC first disclosed a stake in LGND in Q3 2023 at 39,182 shares (US$2.3M). The position peaked in Q2 2026 at 62,043 shares, worth US$19.6M. Across 11 filings, CASTLEARK MANAGEMENT LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 62,043 shares valued at US$19.6M — an increase of 13,347 shares quarter over quarter.. Notable position changes include a 60% increase in Q4 2023 (shares rose 2% over the following quarter), a 27% trim in Q1 2026 (shares rose 58% over the following quarter), a 27% increase in Q2 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 39.18K | $2.35M | New |
| Q4 2023 | 62.70K | $4.48M | Add |
| Q1 2024 | 61.91K | $4.53M | Reduce |
| Q2 2024 | 61.36K | $5.17M | Reduce |
| Q3 2024 | 67.92K | $6.80M | Add |
| Q4 2024 | 65.11K | $6.98M | Reduce |
| Q1 2025 | 66.46K | $6.99M | Add |
| Q3 2025 | 64.68K | $11.46M | New |
| Q4 2025 | 66.74K | $12.62M | Add |
| Q1 2026 | 48.70K | $9.72M | Reduce |
| Q2 2026 | 62.04K | $19.61M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 58 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 475.61K sh · $150.34M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K sh · $85.36M · Q2 2026
- Ranger Investment Management, L.P. 257.60K sh · $81.42M · Q2 2026
- GW&K Investment Management, LLC 246.88K sh · $78.04M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 198.54K sh · $62.76M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K sh · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- VILLERE ST DENIS J & CO LLC 155.51K sh · $49.15M · Q2 2026
- Granahan Investment Management, LLC 147.23K sh · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 100.34K sh · $31.75M · Q2 2026
More on CASTLEARK MANAGEMENT LLC
FAQ
How long has CASTLEARK MANAGEMENT LLC held LGND?
CASTLEARK MANAGEMENT LLC has disclosed LGND holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is CASTLEARK MANAGEMENT LLC's current position in LGND?
As of Q2 2026, CASTLEARK MANAGEMENT LLC holds 62.04K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $19.61M, representing 0.53% of its reported portfolio and ranking #34.
Has CASTLEARK MANAGEMENT LLC been buying or selling LGND?
In the latest 13F filing (Q2 2026), CASTLEARK MANAGEMENT LLC increased its position in LGND. The position peaked in Q2 2026 at 62.04K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.